In the realm of inflammatory bowel disease (IBD), HSD have been shown to precipitate the synthesis of interleukin-23 (IL-23), concomitantly enriching the population of IL-17-producing type 3 innate lymphoid cells (ILC3s), thus aggravating intestinal inflammation 34,35. The gene discussed is IL17A; the disease is gastroenteritis.